Citations

Clear

3138 citation(s) found for "Smith, AM".

On the fiftieth anniversary Postinfectious irritable bowel syndrome: mechanisms related to pathogens
Grover, Madhusudan , Camilleri, Michael , Smith, Kirk , Farrugia, Gianrico , Linden, David R.

Mayo Clinic

Neurogastroenterology & Motility | January 19, 2014 | Volume: 26 | Issue: 2 | Pages: 156-167

10.1111/nmo.12304 | PMID 24438587 Get It

Abstract Background Gastrointestinal ( GI ) infections resulting from bacterial, viral, and parasitic pathogens predispose to postinfectious irritable bowel syndrome ( PI ‐ IBS ) and other functional GI disorders. Existing literature supports the role of enterochromaffin cell hyperplasia, serotonin synthesis and reuptake, impaired barrier function, altered immune activation, and potentially mast cell activation in the pathophysiology of PI ‐ IBS . Purpose The objective of this review was to summarize from the literature the characteristics of the pathogens commonly implicated in PI ‐ IBS , their acute enteritis phases, and the changes seen in the postinfectious phase that may contribute toward development of IBS . A limitation of our current understanding is that the postinfectious GI sequelae reported in prior studies followed epidemic diarrheal outbreaks often involving more than one pathogen, or the studies focused on highly selected, tertiary referral patients. Understanding the mechanisms, natural history, and optimized management of individuals suffering PI ‐ IBS following the more typical sporadic infection requires larger studies of PI ‐ IBS following GI infections encountered in community settings. These studies should include genetic, physiological, and molecular studies to provide more generalizable information that can ultimately be used to diagnose, manage, and potentially prevent the development of PI ‐ IBS .
Population-Based Study of Severe Hypoglycemia Requiring Emergency Medical Service Assistance Reveals Unique Findings
Parsaik, Ajay K. , Carter, Rickey E. , Pattan, Vishwanath , Kumar, Hamit, Smith, Steven A., Russi, Christopher S. , Levine, James A. , Basu, Ananda , Kudva, Yogish C. , Myers, Lucas A. , Carter, Rickey E

Mayo Clinic

Journal of Diabetes Science and Technology | January 10, 2014 | Volume: 6 | Issue: 1 | Pages: 65-73

10.1177/193229681200600109 | PMID 22401324 Get It

Objective: The objective is to report a contemporary population-based estimate of hypoglycemia requiring emergency medical services (EMS), its burden on medical resources, and its associated mortality in patients with or without diabetes mellitus (DM, non-DM), which will enable development of prospective strategies that will capture hypoglycemia promptly and provide an integrated approach for prevention of such episodes. Methods: We retrieved all ambulance calls activated for hypoglycemia in Olmsted County, Minnesota, between January 1, 2003 and December 31, 2009. Results: A total of 1473 calls were made by 914 people (DM 8%, non-DM 16%, unknown DM status 3%). Mean age was 60 ± 16 years with 49% being female. A higher percentage of calls were made by DM patients (87%) with proportionally fewer calls coming from non-DM patients (11%) (chi-square test, p < .001), and the remaining 2% calls by people with unknown DM status. Emergency room transportation and hospitalization were significantly higher in non-DM patients compared to DM patients ( p < .001) and type 2 diabetes mellitus compared to type 1 diabetes mellitus ( p < .001). Sulphonylureas alone or in combination with insulin varied during the study period ( p = .01). The change in incidence of EMS for hypoglycemia was tracked during this period. However, causality has not been established. Death occurred in 240 people, 1.2 (interquartile range 0.2–2.7) years after their first event. After adjusting for age, mortality was higher in non-DM patients compared with DM patients ( p < .001) but was not different between the two types of DM. Conclusions: The population burden of EMS requiring hypoglycemia is high in both DM and non-DM patients, and imposes significant burden on medical resources. It is associated with long-term mortality.
A Nonsteroidal Anti-Inflammatory Drug, Flufenamic Acid, Inhibits the Expression of the Androgen Receptor in LNCaP Cells
Zhu, Wen, Smith, Aaron L., Young, Charles Y.F.

Mayo Clinic

Endocrinology | January 8, 2014 | Volume: 140 | Issue: 11 | Pages: 5451-5454

10.1210/endo.140.11.7246 | PMID 10537180 Get It

Posttraumatic Fat Necrosis Presenting as Prepatellar Loose Bodies in an Adolescent Football Player
Sole, Joshua S., Wisniewski, Steve J. , Dahm, Diane L., Bond, Jeffrey R., Smith, Jay , Bond, Jeffrey

Mayo Clinic

PM&R | January 3, 2014 | Volume: 6 | Issue: 8 | Pages: 749-752

10.1016/j.pmrj.2013.12.010 | PMID 24389347 Get It

A 16‐year‐old high school football player presented with 4 months of anterior knee pain and small, mobile, prepatellar “lumps” after falling onto an opponent's cleat. He reported knee pain primarily during knee flexion and direct pressure during squatting and kneeling. Knee radiographs were unremarkable. Ultrasonography revealed multiple, freely mobile, subcutaneous nodules of variable size and echogenicity in the prepatellar region. Analysis of magnetic resonance imaging suggested possible fat necrosis but was nondiagnostic. The patient opted for surgical exploration, at which time multiple, opalescent subcutaneous nodules were removed. Pathology was consistent with encapsulated fat necrosis. After surgery, his symptoms resolved, and he returned to sports without restrictions.
Osteoblasts Protect AML Cells From SDF‐1‐Induced Apoptosis
Kremer, Kimberly N. , Dudakovic, Amel , McGee‐Lawrence, Meghan E. , Philips, Rachael L. , Hess, Allan D., Wijnen, André J. van , Karp, Judith E. , Hedin, Karen E. , Smith, B. Douglas , Kaufmann, Scott H. , Westendorf, Jennifer J. , van Wijnen, Andre J , McGee-Lawrence, Meghan E

Mayo Clinic

Journal of Cellular Biochemistry | December 28, 2013 | Volume: 115 | Issue: 6 | Pages: 1128-1137

10.1002/jcb.24755 | PMID 24851270 Get It

ABSTRACTThe bone marrow provides a protective environment for acute myeloid leukemia (AML) cells that often allows leukemic stem cells to survive standard chemotherapeutic regimens. Targeting these leukemic stem cells within the bone marrow is critical for preventing relapse. We recently demonstrated that SDF‐1, a chemokine abundant in the bone marrow, induces apoptosis in AML cell lines and in patient samples expressing high levels of its receptor, CXCR4. Here we show that a subset of osteoblast lineage cells within the bone marrow can protect AML cells from undergoing apoptosis in response to the SDF‐1 naturally present in that location. In co‐culture systems, osteoblasts at various stages of differentiation protected AML cell lines and patient isolates from SDF‐1‐induced apoptosis. The differentiation of the osteoblast cell lines, MC3T3 and W‐20‐17, mediated this protection via a cell contact‐independent mechanism. In contrast, bone marrow‐derived mesenchymal cells, the precursors of osteoblasts, induced apoptosis in AML cells via a CXCR4‐dependent mechanism and failed to protect AML cells from exogenously added SDF‐1. These results indicate that osteoblasts in the process of differentiation potently inhibit the SDF‐1‐driven apoptotic pathway of CXCR4‐expressing AML cells residing in the bone marrow. Drugs targeting this protective mechanism could potentially provide a new approach to treating AML by enhancing the SDF‐1‐induced apoptosis of AML cells residing within the bone marrow microenvironment. J. Cell. Biochem. 115: 1128–1137, 2014. © 2013 Wiley Periodicals, Inc.
Laparoscopic Cholecystectomy in Patients with HeartMate II Left Ventricular Assist Devices
Eck, Dustin L., Belli, Erol, Smith, C. Daniel , Stauffer, John , A Stauffer, John

Mayo Clinic

Journal of Laparoendoscopic & Advanced Surgical Techniques | December 24, 2013 | Volume: 24 | Issue: 2 | Pages: 100-103

10.1089/lap.2013.0460 | PMID 24368008 Get It

Abstract Introduction: With an expanding population of patients requiring ventricular assist devices, it is inevitable that these patients will require noncardiac surgery. Ventricular assist devices provide mechanical support for a failing heart either as a bridge to transplant or now as a long-term support if transplant is not available, so-called destination therapy. These devices can add significant technical challenges to abdominal surgery, in that the power supply and drivelines crossing the abdomen can potentially be damaged. The use of preoperative or intraoperative imaging may aid in locating these devices and increase patient safety. Materials and Methods: We describe a laparoscopic cholecystectomy in two patients supported with HeartMate ® II (Thoratec Corp., Pleasanton, CA) left ventricular assist devices. Our use of fluoroscopic guidance in port placement is also described. A literature review was performed to assess the frequency of laparoscopic procedures performed on patients with similar ventricular assist devices and of complications associated with the device and other comorbidities. Results: Laparoscopic cholecystectomy was performed without significant intraoperative hemodynamic changes. The use of imaging, such as fluoroscopy, can identify the location of the ventricular assist device and its associated drive wires to assure they are not damaged intraoperatively. Conclusions: Laparoscopic cholecystectomy can be performed safely on patients with ventricular assist devices. Complications due to damage to the device can be avoided with the assistance of fluoroscopy to identify the implanted abdominal portions of the ventricular assist device. Each laparoscopic procedure performed on these patients presents the surgeon with unique obstacles in which careful operative planning and intraoperative monitoring are essential.
Gender and Spondyloarthropathy-Associated Uveitis
Smith, Wendy M.

Mayo Clinic

Journal of Ophthalmology | December 22, 2013 | Volume: 2013 | Issue: No issue available | Pages: 1-6

10.1155/2013/928264 | PMID 24455197 Get It

Spondyloarthropathies encompass a group of inflammatory diseases with arthritis and other features such as enthesitis and dermatologic and gastrointestinal involvement. Up to 37% of spondyloarthropathy patients may develop uveitis which is typically bilateral asynchronous acute anterior uveitis. Spondyloarthropathies with and without uveitis are more prevalent among males; the reasons for gender imbalance are unclear. This review will focus on gender differences in the prevalence, incidence, clinical manifestations, and prognosis of uveitis associated with spondyloarthropathies.
DNA mismatch repair gene MSH6 implicated in determining age at natural menopause
Perry, John R. B. , Hsu, Yi-Hsiang, Johnson, Andrew D. , Elks, Cathy E., Albrecht, Eva, Andrulis, Irene L. , Berenson, Gerald S., Bojesen, Stig E. , Bolla, Manjeet K. , Brown, Judith, Buring, Julie E. , Campbell, Harry, Chang‐Claude, Jenny , Chenevix‐Trench, Georgia , Corre, Tanguy , Cox, Angela , Czene, Kamila , D’Adamo, Pio , Davies, Gail , Deary, Ian J. , Easton, Douglas F. , Engelhardt, Ellen G. , Eriksson, Johan G. , Fasching, Peter A. , Figueroa, Jonine D. , Flyger, Henrik, Fraser, Abigail , García‐Closas, Montserrat , Gasparini, Paolo , Gieger, Christian , Giles, Graham G. , Guénel, Pascal , Hägg, Sara , Hayward, Caroline , Hopper, John L. , investigators, kConFab, Kardia, Sharon L. R., Kasiman, Katherine, Knight, Julia A. , Lahti, Jari , Lawlor, Debbie A. , Magnusson, Patrik K. E. , Margolin, Sara , Marsh, Julie , Polašek, Ozren , Rahman, Iffat , Ridker, Paul M., Robino, Antonietta , Rudan, Igor , Salumets, Andres , Schmidt, Marjanka K. , Schoemaker, Minouk J. , Smith, Erin N. , Smith, Jennifer A. , Southey, Melissa C. , Stöckl, Doris, Swerdlow, Anthony J. , Thompson, Deborah J. , Truong, Thérèse , Ulivi, Sheila , Waldenberger, Mélanie , Wang, Qin , Wright, Alan F., Zgaga, Lina , Karasik, David , Murray, Anna , Uitterlinden, André G. , Hsu, Yi‐Hsiang , Chasman, Daniel I. , Beesley, Jonathan , Bergmann, Sven M. , Couch, Fergus J. , Dennis, Joe , Esko, Tõnu , Hall, Per N , Ingelsson, Erik , investigators, kConFab, Metspalu, Andres , Olson, Janet E. , Pennell, Craig Edward , Rudolph, Anja , Wild, Sarah H. , Wilson, James Fox , Ong, Ken K. , Murabito, Joanne M. , Giles, Graham G , Swerdlow, Anthony J , Smith, Jennifer A , Southey, Melissa C , Cox, Angela , Guénel, Pascal , García-Closas, Montserrat , Schmidt, Marjanka K , Chenevix-Trench, Georgia , Figueroa, Jonine D , Czene, Kamila , Bojesen, Stig E , Schoemaker, Minouk J , Truong, Therese

Mayo Clinic

Human Molecular Genetics | December 20, 2013 | Volume: 23 | Issue: 9 | Pages: 2490-2497

10.1093/hmg/ddt620 | PMID 24357391 Get It

Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality
Fenske, Timothy S. , Zhang, Mei-Jie , Carreras, Jeanette, Ayala, Ernesto , Burns, Linda J. , Cashen, Amanda F. , Costa, Luciano J. , Freytes, César O. , Holmberg, Leona , Inwards, David J. , Munker, Reinhold , Rizzieri, David A. , Schouten, Harry C. , Smith, Sonali M. , Waller, Edmund K. , Wirk, Baldeep , Laport, Ginna G. , Maloney, David G. , Montoto, Silvia , Hari, Parameswaran , Holmberg, Leona , Zhang, Mei‐Jie , Gale, Robert Peter , Hamadani, Mehdi , Lazarus, Hillard M. , Maziarz, Richard Thomas , Perales, Miguel‐Angel , Waller, Edmund K , Montoto, Silvia , Costa, Luciano J , Hari, Parameswaran

Mayo Clinic

Journal of Clinical Oncology | December 17, 2013 | Volume: 32 | Issue: 4 | Pages: 273-281

10.1200/jco.2013.49.2454 | PMID 24344210 Get It

PurposeTo examine the outcomes of patients with chemotherapy-sensitive mantle-cell lymphoma (MCL) following a first hematopoietic stem-cell transplantation (HCT), comparing outcomes with autologous (auto) versus reduced-intensity conditioning allogeneic (RIC allo) HCT and with transplantation applied at different times in the disease course.Patients and MethodsIn all, 519 patients who received transplantations between 1996 and 2007 and were reported to the Center for International Blood and Marrow Transplant Research were analyzed. The early transplantation cohort was defined as those patients in first partial or complete remission with no more than two lines of chemotherapy. The late transplantation cohort was defined as all the remaining patients.ResultsAuto-HCT and RIC allo-HCT resulted in similar overall survival from transplantation for both the early (at 5 years: 61% auto-HCT v 62% RIC allo-HCT; P = .951) and late cohorts (at 5 years: 44% auto-HCT v 31% RIC allo-HCT; P = .202). In both early and late transplantation cohorts, progression/relapse was lower and nonrelapse mortality was higher in the allo-HCT group. Overall survival and progression-free survival were highest in patients who underwent auto-HCT in first complete response. Multivariate analysis of survival from diagnosis identified a survival benefit favoring early HCT for both auto-HCT and RIC allo-HCT.ConclusionFor patients with chemotherapy-sensitive MCL, the optimal timing for HCT is early in the disease course. Outcomes are particularly favorable for patients undergoing auto-HCT in first complete remission. For those unable to achieve complete remission after two lines of chemotherapy or those with relapsed disease, either auto-HCT or RIC allo-HCT may be effective, although the chance for long-term remission and survival is lower.